Dr. Romana Haneef discusses the development of the French national burden of disease study
-
Spotlight
The burden-eu COST Action wants to put its members in the spotlight! Spotlights are short (500-1000 words) blogposts where network members present their work in a personal and vulgarizing way. The spotlights also describe how the presented work benefited from the COST Action.
Do you have a recent publication or new project related to burden of disease? Please let us know via , and we will be happy to put you in the spotlight!
Dr. Alexander Rommel discusses the burden of disease due to COVID-19 (BoCO-19) initiative targeted to lower-middle income countries to monitor the population health impact of the COVID-19 pandemic.
Dr. Lea Sletting Jakobsen discusses her experiences as an early career researcher working on the disease burden associated with dairy products.
Dr. Sarah Cuschieri's experience of participating in our COST action
Dr. Aline Anton describes how the BURDEN 2020 study has estimated the prevalence and severity of headaches in Germany
Dr. Zubair Kabir describes the development of the GBD-Frailty Index, a novel population-based standardised metric for frailty.
About COST
COST (European Cooperation in Science and Technology – see www.cost.eu) is a unique platform where European researchers can jointly develop their ideas and initiatives across all scientific disciplines through trans-European networking of nationally funded research. COST is supported by the European Union (EU) Horizon 2020 Programme.
Useful links
Get in touch
COST is supported by the EU Framework Programme Horizon 2020
Website by
